Leslie Bernstein, PhD, Professor and Director of the Department of Cancer Etiology and Dean for Faculty Development at City of Hope, received two major awards within about two weeks of each other. The first, the American Association for Cancer Research-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research, is given annually to a scientist for contributions to the field of cancer prevention in basic, translational, clinical, epidemiological, or behavioral science. Dr. Bernstein was honored for her nearly 25 years of research discoveries on the effects of hormones and physical activity on cancer risk, the late effects of cancer treatment, the impact of lifestyle on cancer prognosis, and quality of life after cancer. She also was the recipient of the 2007 Brinker Clinical Research Award for Scientific Research, which was given in December at the San Antonio Breast Cancer Symposium.
The Brinker Award for Basic Science was given to Joe W. Gray, PhD, Associate Laboratory Director for Life and Environmental Science and Life Sciences Director at Lawrence Berkeley National Laboratory and Adjunct Professor of Laboratory Medicine at the University of California, San Francisco. Dr. Gray was honored for his pioneering research in the development of innovative biomedical technologies such as transcriptional profiling, high-throughput analysis, SNP array CGH, and molecular inversion problems.
The award was given at a dinner in his and Dr. Bernstein's honor at the San Antonio Breast Cancer Symposium.
Martine Extermann, MD, PhD, Associate Professor in the Senior Adult Oncology Program at Moffitt Cancer Center, has been elected President of the International Society of Geriatric Oncology for a two-year term starting this fall.
Ernest T. Hawk, MD, MPH, has joined M. D. Anderson Cancer Center as Vice President and Head of the Division of Cancer Prevention and Population Sciences. He was previously at the NCI, where he was Director of the Office of Centers, Training, and Resources. He succeeds Bernard Levin, MD, retiring after 23 years at M. D. Anderson, where he founded that Division.
MammaPrint, a new Dutch breast cancer test, has been named Best Invention of 2007 by Time Magazine. The device measures the activity levels of 70 genes in a sample taken from a woman's surgically removed breast cancer tumor to determine whether there is a low or high risk of metastasis.